| |
|
|
|
Kezar Life Sciences Inc  
|
|
8.86 -0.23 (-0.03%) |
09-16 16:00 |
|
Open: |
9.02 |
Pre close: |
9.09 |
Target:
|
10.99
|
|
High: |
9.23 |
Low: |
8.51 |
Resistance:
|
9.41
10.99
|
|
Volume: |
247,781 |
Market Cap: |
427M |
Support:
|
6.88
5.32
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
8.43
 |
MACD |
MACD(12,26):
|
0.74 |
|
MA(20): |
7.43 |
Signal(12,26,9): |
0.64 |
|
MA(100): |
5.91 |
Stochastic Oscillator |
%K(14,3):
|
88.05 |
|
MA(250): |
5.77 |
%D(3): |
82.49 |
|
Average Volume(K) |
3-Month: |
936140
|
52-Week |
High:
|
9.41 |
|
10-Days: |
431654 |
Low: |
4.34 |
|
RSI |
RSI(14):
|
71.48  |
Change(%): |
76.1 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.920 |
Return on Equity (ttm) |
-33.4 |
Shares Out. (M) |
48.09 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-19.8 |
Shares Float (M) |
30.93 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
30.40 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
60.69 |
|
Forward EPS |
-1.840 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
2560 |
|
Book Value (p.s.) |
2.920 |
EBITDA (p.s.) |
-0.980 |
P/E |
-9.63 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
3.03 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-39.96 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-23.09 |
P/CF |
-10.66 |
|
|
|
|
|
|
